Back to Search
Start Over
Customization and external validation of the Simplified Mortality Score for the Intensive Care Unit (SMS-ICU) in Brazilian critically ill patients.
- Source :
-
Journal of critical care [J Crit Care] 2020 Oct; Vol. 59, pp. 94-100. Date of Electronic Publication: 2020 May 29. - Publication Year :
- 2020
-
Abstract
- Purpose: To customize and externally validate the recently proposed Simplified Mortality Score for the ICU (SMS-ICU, a simple score for 90-day mortality that has no need for ancillary testing results) for in-hospital mortality and to compare its performance to SAPS 3.<br />Material and Methods: We used data from two distinct large cohorts of adult Brazilian patients with unplanned ICU admissions to perform a first-level customization (43,017 patients admitted to 78 ICUs) of the original SMS-ICU score for in-hospital mortality and, sequentially, externally validate it (313,365 patients admitted to 99 ICUs). Performance of SMS-ICU was assessed through measurements of discrimination and calibration and compared with SAPS 3.<br />Results: In the validation cohort, median SMS-ICU was 13 (IQR 8-16) points and median SAPS 3 was 44 (IQR 36-51). Discrimination of SMS-ICU was good (AUC 0.817; 95% CI 0.814-0.819) but slightly lower than of SAPS 3 (AUC 0.845; 95% CI 0.843-0.848;). The customized SMS-ICU predictions were comparable to SAPS 3 in terms of calibration.<br />Conclusion: In this external validation of the SMS-ICU in a large Brazilian cohort, we observed good discrimination of SMS-ICU and acceptable calibration after first-level customization. SMS-ICU can be used as a measure of illness severity for acutely admitted ICU patients in clinical studies.<br />Competing Interests: Declaration of Competing Interest MS and JIFS are proprietary and founder of Epimed Solutions®, a cloud-based registry for intensive care units that was used for the ORCHESTRA database. AG, AP, and MHM were involved in the development of the SMS-ICU. The ICU, Rigshospitalet receives fund for other research projects from Ferring Pharmaceuticals, Denmark, and the Novo Nordisk Foundation, Denmark.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1557-8615
- Volume :
- 59
- Database :
- MEDLINE
- Journal :
- Journal of critical care
- Publication Type :
- Academic Journal
- Accession number :
- 32585439
- Full Text :
- https://doi.org/10.1016/j.jcrc.2020.05.016